Investor Relations 1Q 2017
|
|
- Sophia Stevenson
- 6 years ago
- Views:
Transcription
1 Investor Relations 1Q 2017
2 History Leading Authentic Sports Brand Inspired by the Style, Elegance and Passion of our Italian Heritage Founded by FILA brothers in Biella, Italy Established FILA Korea FILA Korea acquired FILA trademark and global assets (USD 400M LBO) FILA Korea & Mirae Asset Global Investments Consortium acquired Acushnet Holdings Corp. (USD 1.2B LBO) First sports apparel market (Tennis) FILA Korea MBO FILA Korea IPO (081660:KS) FILA Korea acquired additional 20% stake of Acushnet Holdings Corp. 1
3 Group Structure Magnus Holdings 100% FILA Korea (Controlling Shareholder) 51% GLBH Korea 53% 100% Acushnet Holdings Corp. GLBH Holdings (Acquisition Vehicle) 100% FILA Luxembourg (Trademark Owner) Licensee (Global Royalty) 15% 100% 100% Full Prospect (JV with ANTA) FILA USA (USA, Canada, Mexico) FILA Sport HK (In-house Sourcing) 2
4 FILA Group Business Overview Direct FILA Korea FILA USA Apparel and footwear based retail and wholesale distributor Total number of stores: 618 (as of 1QE 2017) Multi-brand: FILA, FILA GOLF, FILA KIDS, FILA UNDERWEAR North America (U.S.A., Canada, Mexico) Footwear based wholesale distributor FILA Licensee Total 33 licensees in EMEA, North America, Latin America and Asia Stable revenue and profit contribution from licensee partners that operate the FILA branded products globally Indirect FILA China Joint venture with ANTA Sports from Offering premium sports & lifestyle products in China, Hong Kong, and Macau Contributes 3% of its wholesale revenue as Design Service Fee to FILA Korea Fast growth in revenue since its launching year Acushnet Hold. Magnus Holdings Co., Ltd., a wholly-owned subsidiary of Fila Korea Co., Ltd., or Fila Korea, owns approximately 53% of Acushnet Holdings Corp. as a controlling shareholder. Acushnet Holdings Corp. designs, develops, manufactures, and distributes golf products worldwide. The company operates through four segments: Titleist Golf Balls, Titleist Golf Clubs, Titleist Golf Gear, and FootJoy Golf Wear. Owned brands: Titleist, FootJoy, Vokey, Scotty Cameron, Pinnacle 3
5 FILA A Leading Authentic Global Sports Brand Expanding into upper channels of distribution in the US: Foot Locker, Bloomingdale s, Macy s, Nord -strom, Neiman Marcus etc. Brand renewal in Korea Distribution channel re-structuring process Various collaboration reflecting Heritage trend Successful product collaborations including Urban Outfitters, Baja East, Gosha Rubchinskiy, Marion Bartoli (LOVE FILA by Marion Bartoli), Nas (Nas x Ghostbusters footwear collection, Mountain Dew, Staples etc.) Successfully established FILA as leading high-end lifestyle casual brand in China Collaborations with Anna Sui, Jason Wu and Ginny Hilfiger Total of 33 licensees Led by Anta, a leading sports apparel company in China, FILA has been expanding into major markets across China, Hong Kong and Macau 4
6 Global License Business Global License Structure (33 licensees) General License Conditions FILA Luxembourg (Trademark owner) License period is 5 years (10 years for master licensees) Based on the wholesale revenue from each licensee Avg. 6-7% of FILA s wholesale revenue Asia 10 regional licensees North America 7 regional licensees EMEA 1 master licensees South America 1 master licensee Global Product 7 category licensee Each licensee has minimum guaranteed royalty (MGR) based on the forecasted revenue Semi-annual Global Collaboration Meetings (GCM) held to set broad, global strategic guidelines among all licensees 7 regional licensees 5
7 Consolidated Financial Summary 1Q Revenue Breakdown / OPM (Consol.) (KRW M) FILA Korea FILA USA Royalty & Others Acushnet Hold. OPM Annual Revenue Breakdown / OPM (Consol.) (KRW M) FILA Korea FILA USA Royalty & Others Acushnet Hold. OPM 215, , , , , ,128 15% 10% 13% 13% 23% 49% 51% 77% 37% 44% 7% 38% 37% 12.9% 39% 3.8% 3% 10% 7.5% 10% 50% 43% 32% 11.7% 9.9% 1.2% 1Q Q Q 2017 FY 2014 FY 2015 FY
8 FILA Korea From 2012 Korean economic turmoil created rough environment for many consumer businesses and FILA Korea has started brand restructuring in early Q Revenue Breakdown / OPM (KRW M) (KRW M) Annual Revenue Breakdown / OPM Revenue OPM Revenue OPM 79, ,490 65,458 66, , ,179 Deficit -0.7% Deficit -12.3% Deficit -12.9% 3.0% Deficit -1.2% Deficit -10.1% 1Q Q Q 2017 FY 2014 FY 2015 FY
9 FILA F IUSA L A Consolidated U S A (Canada and Mexico) Despite the competitive market conditions in the US, FILA USA is continuously penetrating into the upper distribution channel to build broader brand presence 1Q Revenue Breakdown / OPM (USD K) (USD K) Annual Revenue Breakdown / OPM Revenue OPM Revenue OPM 94, , ,928 71,436 60, , % 6.3% 6.2% 6.2% 6.7% Deficit -5.0% 1Q Q Q 2017 FY 2014 FY 2015 FY
10 Global Royalty Stable revenue and profit contribution from 33 licensee partners that operate the FILA branded products globally 1Q Royalty Breakdown (USD K) (USD K) Annual Royalty Breakdown Asia N.America S.America EMEA Others Asia N.America S.America EMEA Others 8,558 6,882 8,840 4% 7% 5% 2% 3% 4% 38% 37% 39% 46% 39% 43% 4% 8% 20% 25% 19% 26% 30% 25% 39,061 36,743 34,231 3% 4% 5% 38% 37% 41% 8% 7% 3% 27% 26% 22% 25% 31% 34% 24% 26% 29% -3% 1Q Q Q 2017 FY 2014 FY 2015 FY
11 Appendix Consolidated Balance Sheet (K-IFRS) (KRW M) 1Q 2017 FY 2016 FY 2015 Assets 3,252,531 3,384, ,932 Current Assets 1,273,569 1,240, ,786 Cash and cash equivalents 149, ,389 46,938 Trade and other receivables 517, , ,500 Inventories 546, , ,208 Other current assets 58,717 82,178 13,140 Non-current Assets 1,978,962 2,143, ,146 Property and equipment 317, ,467 44,531 Intangible assets 1,503,031 1,626, ,637 Other non-current assets 158, , ,978 Liabilities 2,041,501 2,082, ,830 Current Liabilities 1,182,977 1,193, ,629 Trade and other payables 311, , ,402 Borrowings 711, , ,037 Bonds 72, Other current liabilities 87,788 96,214 20,190 Non-current Liabilities 858, , ,200 Borrowings 581, ,438 92,572 Bonds - 78,083 75,363 Other non-current liabilities 276, ,195 60,265 Total Equity 1,211,030 1,302, ,102 10
12 Appendix Consolidated Profit & Loss Summary (KRW M) FY Q Q Q Q 2015 FY Q Q Q Q 2016 FY Q 2017 Revenue 797, , , , , , , , , , , ,701 Gross Profit 376,996 96,541 97,871 86,219 88, ,878 71,985 99,263 74, , , ,576 G.P.(%) 47.30% 44.90% 48.80% 43.90% 43.40% 45.20% 42.80% 47.44% 42.63% 41.75% 43.32% 47.05% Operating Profit 93,549 27,657 25,200 19,158 8,546 80,562 6,305 24,807 6,225-25,500 11,838 48,882 O.P.(%) 11.70% 12.90% 12.60% 9.80% 4.20% 9.90% 3.75% 11.86% 3.55% -6.16% 1.22% 7.48% Net Income 57,590-30,609-31,692-19,882-51, ,328 7,340 16,009-69, , ,126 25,539 FILA Korea Profit & Loss Summary (KRW M) FY Q Q Q Q 2015 FY Q Q Q Q 2016 FY Q 2017 Revenue 397,490 79, ,484 76,485 90, ,805 65,458 86,052 72,401 82, ,179 66,185 Gross Profit 220,669 45,078 58,391 42,080 47, ,692 31,459 50,553 34,660 40, ,750 32,752 G.P.(%) 55.50% 56.90% 58.10% 55.00% 52.00% 55.60% 48.10% 58.70% 47.90% 48.70% 51.20% 49.49% Operating Profit 11, ,937-1,670-6,738-4,020-8, ,585-13,608-31,021-8,545 O.P.(%) 3.00% -0.69% 4.91% -2.18% -7.43% -1.16% % 0.27% % % % % Net Income 9, , , ,523 3,547-18,679 4,811-17,845-13,008 11
13 Appendix FILA USA Consolidated Profit & Loss Summary (USD K) FY Q Q Q Q 2015 FY Q Q Q Q 2016 FY Q 2017 Revenue 279,231 94,957 71,310 75,984 78, ,990 71,436 90,427 75,237 82, ,928 60,285 Gross Profit 82,482 29,892 20,054 22,618 21,842 94,406 22,529 28,951 22,892 24,137 98,509 17,329 G.P.(%) 29.50% 31.50% 28.10% 29.80% 27.70% 29.40% 31.50% 32.00% 30.40% 29.10% 30.80% 28.75% Operating Profit 17,225 8,833 4,299 4,130 2,682 19,944 4,495 6,804 4,542 5,458 21,299-3,042 O.P.(%) 6.20% 9.30% 6.00% 5.40% 3.40% 6.20% 6.30% 7.50% 6.00% 6.60% 6.70% -5.05% Net Income 8,782 5,164 2,375 1,945 1,406 10,890 2,409 3,924 2,508 2,763 11,604-2,002 Global Royalty Summary (USD K) FY Q Q Q Q 2015 FY Q Q Q Q 2016 YTD Q 2017 FILA Korea 8,634 1,508 1,898 1,386 1,616 6,408 1,148 1,540 1,342 1,420 5, FILA Subsidiary 11,070 5,417 2,638 3,176 1,558 12,927 2,465 5,411 1,971 2,747 12,594 2,079 Asia 9,384 2,110 2,133 2,027 3,206 9,478 2,118 2,128 2,057 3,586 9,886 3,104 North America 10,506 2,170 2,223 2,749 2,303 9,427 1,279 1,961 2,346 2,035 7,621 1,780 South America 3, , , EMEA 14,751 3,227 3,363 3,553 3,504 13,645 3,243 3,354 3,977 3,485 14,057 3,239 Category 1, , , ,765 15,483 13,528 13,800 13,147 56,078 10,495 15,217 12,533 14,036 52,275 11,710 Total (Adjusted) 39,061 8,558 8,992 9,219 9,973 36,743 6,882 8,266 9,220 9,869 34,231 8,840 12
14 Disclaimer This document has been prepared for presentation, illustration and discussion purpose only and is not legally binding. Whilst complied from sources FILA Korea believes to be accurate, no representation, warranty, assurance or inducement express or implied as to the accuracy, completeness or adequacy of freedom from defect of any kind is made, and the division, group or subsidiary or affiliate of FILA Korea which produced this document shall not be liable to the recipient or controlling shareholders of the recipient resulting from its use. Nothing herein contains shall be construed as granting the recipient whether directly or indirectly or by implication, any license or right, under any copy right or intellectual property rights to use the information herein. FILA Korea accepts no liability for any loss or damage of any kind resulting out of the unauthorized use of this document. Investment involves risk. Past performance figures are not indicative of future performance. Please carefully read through the documents and seek independent professional advice before you make any investment decision. 13
Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011
Hyundai Motor Company 1 st Quarter 2011 Business Results April 28, 2011 Cautionary Statement with Respect to Forward-Looking Statements In the presentation that follows and in related comments by Hyundai
More information1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes
1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements
More informationInvestor Presentation
ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an
More informationDELICA D:5 ACTIVE GEAR 0
DELICA D:5 ACTIVE GEAR 0 1 1. FY2017 1Q Results 2. FY2017 1Q Results by Region 3. FY2017 Forecast 4. Initiatives for the Future FY2017 1Q Results Summary (vs. FY2016 1Q) (Apr-Jun 2016) (Apr-Jun 2017) (billion
More informationFor personal use only
ASX RELEASE (23 rd March 2018) AGM PowerPoint Presentaion In accordance with the requirements of Listing Rule 3.1 we submit the attached material being distributed at the Company s Annual General Meeting
More informationSummary Statement of Financial Position (consolidated)
2012. 5. 3. 1 Disclaimer This presentation is for informational purposes only, contains preliminary financial and other information about Korean Air Lines Co., Ltd. and is subject to updating, revision,
More informationDIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM
November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf
More informationTotal Face Group Limited
Total Face Group Limited 2017 Half Year Results Presentation Contents Results Highlights Highlights Half Year Results Revenue Bridge Revenue Breakdown Clinic Profitability Profit & Loss Financial Position
More informationAcquisition of Novartis Influenza Vaccines Business. 27 th October 2014
1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include
More informationThird-quarter results 2013
Third-quarter results 213 Fornebu, 6 November 213 Øyvind Eriksen and Leif Borge Agenda 213 Introduction Øyvind Eriksen Executive chairman Financials Leif Borge President & CFO Q&A Q&A session Øyvind Eriksen
More informationFor personal use only
Cochlear Limited Results for the half year ended 31 December 2011 (H1 F12) Chris Roberts, CEO Neville Mitchell, CFO Cochlear Overview Cochlear Limited (ASX:COH): global leader in implantable devices for
More informationQUALITAS MEDICAL GROUP LIMITED. CORPORATE PRESENTATION January 2010
QUALITAS MEDICAL GROUP LIMITED CORPORATE PRESENTATION January 2010 Contents Our Business Corporate Developments Growth Strategies Financial Highlights Summary Business Overview Who We Are Established in
More informationShareholder Presentation Annual Meeting 2018
Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)
More informationKorean Airlines Q Results
Korean Airlines 2010 2Q Results 2010. 8. 13 1 Disclaimer This presentation is for informational purposes only, contains preliminary financial and other information about Korean Air Lines Co., Ltd. and
More informationQ Investor Kit JANUARY-MARCH 2014
Q1 2014 Investor Kit JANUARY-MARCH 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco
More informationWoongjin Coway. 1Q 12 IR Presentation
Woongjin Coway 1Q 12 IR Presentation Disclaimer This presentation contains historical information of the company which should not be regarded as an indication of the future performance or results. This
More informationSummary of Results for the First Half of FY2015/3
Summary of Results for the First Half of FY2015/3 November 10, 2014 Tokyu Corporation (9005) http://www.tokyu.co.jp/ Contents Ⅰ.Executive Summary 2 Ⅱ.Conditions in Each Business 5 Ⅲ.Details of Financial
More information1Q2017 法人說明會 Jun. 9, 2017
1Q2017 法人說明會 Jun. 9, 2017 FE group business Span over 10 major industries Own over 240 companies Established in 1937 9 public listed companies in Taiwan and HK Petrochemical & energy Polyester & synthetic
More informationQ Investor Kit JANUARY-MARCH 2013
Q1 2013 Investor Kit JANUARY-MARCH 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)
More informationA world leader in allergy immunotherapy
A world leader in allergy immunotherapy Investor Relations presentation June 2017 1 I Investor Relations presentation I June 2017 ALK: Towards redefining treatment of severe allergies The commercial leader
More informationPRESENTATION ON 2017 THIRD QUARTERLY RESULTS
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness
More informationQ Investor Kit JANUARY-JUNE 2013
Q2 2013 Investor Kit JANUARY-JUNE 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)
More informationFinancial Presentation
Financial Presentation Certain of the statements that will be made during this meeting, as well as statements contained in our 2006 Annual Report to Shareholders and Annual Report on Form 10-K filed with
More informationIncrease in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014
Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) ( ) H1 2014 revenues and results - 24 July 2014 Forward-looking statement This presentation contains
More informationFY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009
FY2009 First Quarter Financial Results SUZUKI MOTOR CORPORATION August 3, 2009 Consolidated: Financial Summary Page 2 FY2009 1Q FY2008 4Q 09/4-6 09/1-3 Change FY2008 1Q 08/4-6 Change (Billion Yen) (A)
More informationELICA 2012 Q3 RESULTS. November 14,
ELICA ELICA 1 Q3 12 Highligths Negative market demand, showing better trend compared to previous quarters Group sales over performing in all major markets Cost reduction efforts and continued product innovation
More informationGlobal Cosmetic Dentistry Market Research Report 2018
Report Information More information from: https://www.wiseguyreports.com/reports/3029111-global-cosmetic-dentistry-market-research-report- 2018 Global Cosmetic Dentistry Market Research Report 2018 Report
More informationQ Investor Kit JANUARY-JUNE 2014
Q2 2014 Investor Kit JANUARY-JUNE 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco
More informationA GLOBAL LEADER IN PERSONALIZED NUTRITION
A GLOBAL LEADER IN PERSONALIZED NUTRITION Forward Looking Statements Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking
More informationQ Investor Kit January December 2014
Q4 2014 Investor Kit January December 2014 Highlights for Q4 Sales up for all product areas and operating profit from product areas up by 8% Scandinavian hoarding for snus prior to tax increase in January
More informationWelcome to LG Electronics
Welcome to LG Electronics April 21, 2004 As a note, this presentation has been prepared based on internal audited figures and final figures may change due to the results of independent auditors review.
More informationFor personal use only
HY18 Result Presentation 13 February 2018 Dig Howitt Brent Cubis CEO & President CFO HY18 Result highlights Strong momentum across developed markets continues Developed market unit growth up 12% Strengthening
More informationPresentation of. Burgdorf, 1 st November 2012
Presentation of Semi-Annual Results 2012/13 Burgdorf, 1 st November 2012 Important Notice The information contained in this document has not been independently verified and no representation or warranty,
More informationThe Dental Corporation Opportunity
The Dental Corporation Opportunity for Practice Principals. It s the perfect professional collaboration. You focus on dentistry, we look after the paperwork. In recognition of what you, the Practice Principal,
More informationTelekom Austria Group Results for the 1st Quarter May 27, 2003
Telekom Austria Group Results for the 1st Quarter 2003 May 27, 2003 1 Cautionary Statement This presentation contains certain forward-looking statements. Actual results may differ materially from those
More informationDabur India Ltd. Investor Presentation June 2016
Dabur India Ltd Investor Presentation June 2016 Dabur Overview One of the oldest and largest FMCG Companies in the country World s largest in Ayurveda and natural healthcare Total reach of 5.3mn outlets,
More informationGlobal Invisible Braces Market: Trends, Opportunities and Forecasts ( )
Global Invisible Braces Market: Trends, Opportunities and Forecasts (2016-2021) By Types Clear Aligners, Ceramic, Lingual By Region Americas, Europe, Middle East, Africa, Asia-Pacific By Country- USA,
More informationSirtex Medical Ltd Buy
Research Sirtex Medical Ltd Buy Price: A$16.32 Price Target: A$20.50 ASX: SRX 21 April 2017 Sirtex Medical (SRX) is a global medical device company which targets cancer therapies, with its lead product
More informationSUMMARY TERM SHEET. Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL )
SUMMARY TERM SHEET Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL ) 2. Date of resolution May 28, 2014 passed by the Board of Directors authorizing the
More informationPROTON THERAPY. Proton Therapy Edition 2016 WORLD MARKET REPORT & DIRECTORY EDITION
Proton Therapy Edition 2016 PROTON THERAPY WORLD MARKET REPORT & DIRECTORY EDITION 2016 A report written by Paul-Emmanuel Goethals & Richard Zimmermann Page 1/7 www.medraysintell.com Proton Therapy Edition
More informationGlobal Hearing Aid Battery Market: Analysis By Battery Type, By Region, By Country: Trends, Opportunities, Restraints (2018 Edition) Forecast to 2022
Global Hearing Aid Battery Market: Analysis By Battery Type, By Region, By Country: Trends, Opportunities, Restraints (2018 Edition) Forecast to 2022 By Value (In Million USD) By Volume (In Million Units)
More informationUroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011
Uroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011 Forward Looking Statement This presentation includes forward-looking statements, including financial projections, relating
More informationInvestment in MGC Pharmaceuticals
Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information
More informationPhotoCure ASA Presentation First quarter 2005 May 3, 2005
PhotoCure ASA Presentation First quarter 2005 May 3, 2005 Obtaining milestones and building value Hexvix Approval in 27 EU/EEA countries, working on national approvals Ongoing phase III study for extended
More informationCPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018
CPH Chemie + Papier Holding AG Investor Day Perlen, 13 th September 2018 Agenda 2.00 pm Welcome 2.05 pm Presentation Course of Business 2018 2.50 pm Break 3.00 pm Presentation Perlen Packaging 3.30 pm
More informationResults Briefing. 15 ~ 17 May 2007
Results Briefing 1Q Q & 3 Months ended 31 Mar. 2007 15 ~ 17 May 2007 Content Key highlights Financial Corporate Financial results Industry overview Q&A Appendix 2 2 Key Highlights for the Period Key Highlights
More informationDiabetic Retinopathy Treatment - Global Market Outlook ( )
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Diabetic Retinopathy Treatment - Global Market Outlook (2015-2022) Diabetic Retinopathy Treatment - Global Market
More informationForward Looking Information
Vital Signs, Inc. Forward Looking Information Except for historical information discussed, the statements made today are forward-looking statements that involve risks and uncertainties. Investors are cautioned
More informationTamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
More informationFor personal use only
Sirtex Medical Limited (ASX:SRX) Macquarie Inaugural Annual Emerging Healthcare Conference Mr Gilman Wong, CEO Mr Darren Smith, CFO Dr David Cade, CMO Wednesday, 10 October 2012 Macquarie Securities Group
More information27 September Interim results for the six months ended 30 June 2018
27 September 2018 Interim results for the six months ended 30 June 2018 Disclaimer 2 Neither this presentation nor any verbal communication shall constitute, or form part of, any offer, invitation or inducement
More informationTHIRD QUARTER REPORT 2011 (UNAUDITED)
THIRD QUARTER REPORT 2011 (UNAUDITED) Kronprinsesse Märthas pl. 1, Vika, 0166 Oslo, Norway. Tel: + 47 23 01 09 60, www.bionorpharma.com Page 1 THIRD QUARTER REPORT 2011 HIGHLIGHTS On the 25th August Bionor
More informationMETVIX PDT ON THE MARKET IN GERMANY AND UK
METVIX PDT ON THE MARKET IN GERMANY AND UK PhotoCure ASA First Quarter Report 2003 Highlights: The launches of Metvix PDT by Galderma in February in Germany and in May in the UK, have triggered milestone
More informationFY2007 Consolidated Financial Overview
FY2007 Consolidated Financial Overview CHUGAI PHARMACEUTICAL CO., LTD. Executive Vice President and CFO Ryuzo Kodama January 30/31, 2008 Forward-Looking Statements This presentation may include forward-looking
More informationPROACTIVE INVESTOR PRESENTATION
www.thcl.com.au ASX RELEASE (16 th May 2017) PROACTIVE INVESTOR PRESENTATION The Hydroponics Company Limited (ASX: THC) is pleased to advise that Dr Andrew Beehag, Chief Executive Officer of Canndeo Limited,
More informationM e d i a s e t G r o u p
M e d i a s e t G r o u p 11 th May 2004 2004 First Quarter Results M e d i a s e t G r o u p BROADCASTING MEDIASET 2004 1Q 24 Hours Audience Trend Individuals Share Points Vs 1Q 2003 OTHER SATELLITE 44.0%
More informationSegment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage
Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years): Forecast to 2022 By Type - Pap Test, HPV Test,
More informationMore information at
Report Information More information at https://www.htfmarketreport.com/reports/1288313 Global Homeopathic Products Market Professional Survey Report 2018 Report Code: HTF1288313 Pages: 111 Price: 1-User
More informationGlobal Standard Radiography Film X-Ray Film Printer Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Standard Radiography Film X-Ray Film Printer Market Research Report 2016 Global Standard Radiography Film
More informationGroup financial results for the first quarter 2008
Helmut Perlet, Member of the Board of Management Group financial results for the first quarter 2008 Journalists Conference Call May 9th, 2008 Group: robust earnings in stormy weather (EUR mn) Quarterly
More informationEndesa 1Q 2017 Results 09/05/2017
Endesa 1Q 2017 Results 09/05/2017 1. Highlights and key financial figures 2. Endesa s performance in 1Q 2017 market context 3. Financial results 4. Final remarks 2 1. Highlights and key financial figures
More informationGlobal Dental Implant Market Research Report 2018
Report Information More information from: https://www.wiseguyreports.com/reports/3220035-global-dental-implant-market-research-report-2018 Global Dental Implant Market Research Report 2018 Report / Search
More informationQ Investor Kit January December 2015
Q4 2015 Investor Kit January December 2015 Summary and Overview 2 Q4 and full year 2015: Headline numbers Sales for the full year increased by 9 percent and for the fourth quarter by 5 percent. In local
More informationFIRSTQUARTER2018 RESULTSPRESENTATION
FIRSTQUARTER2018 RESULTSPRESENTATION May 14 th 2018 Juan Lladó CEO 1 DISCLAIMER This document has been prepared by Técnicas Reunidas S.A. (the Company) solely for use at presentations held in connection
More informationLetter to Shareholders SEMI-ANNUAL REPORT 2008
Letter to Shareholders SEMI-ANNUAL REPORT 2008 Dear Shareholder You have in your hand the first shareholder letter issued by Nobel Biocare. Thanks to the conversion of Nobel Biocare s bearer shares into
More informationVisionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics
Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce
More informationJanuary 30, 2018 Dow Wilson President and Chief Executive Officer
Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking
More informationSirma Group Holding JSC. Consolidated financial statements for the year ending December 31, 2016
Sirma Group Holding JSC Consolidated financial statements for the year ending December 31, 216 Changes in share prices for the period ending 31.12.216 Last trading price on 3.12 1.189 BGN Change in share
More informationResults Presentation 2Q FY March Win-Partners Co., Ltd. (3183)
Results Presentation 2Q FY March 2019 Win-Partners Co., Ltd. (3183) 2Q results ending September 2019 3 Consolidated results summary ( mil)2q to Sep 2017 Sep 2018 YoY OE Sales 29,753 31,863 +7.1% 31,700
More informationWhole Grain and High Fiber - Global Market Outlook ( )
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Whole Grain and High Fiber - Global Market Outlook (2015-2022) Whole Grain and High Fiber - Global Market Outlook
More informationGlobal Magnetic Resonance Imaging (MRI) Systems Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Magnetic Resonance Imaging (MRI) Systems Market Research Report 2016 Global Magnetic Resonance Imaging (MRI)
More informationThe acquisition of Fortitech
The acquisition of Fortitech Accelerating DSM s strategy to become a full solutions provider in food ingredient blends Investor Relations 8 November 2012 Overview Fortitech at a glance Acquisition rationale
More informationSumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company)
December 21, 2016 Sumitomo Dainippon Pharma Co., Ltd. Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company) Sumitomo Dainippon Pharma Co., Ltd. (Head office: Osaka,
More informationDS-8201 Strategic Collaboration
DS-8201 Strategic Collaboration DAIICHI SANKYO CO., LTD George Nakayama Chairman and CEO March 29, 2019 Forward-Looking Statements Management strategies and plans, financial forecasts, future projections
More informationClinical Review Report (Sample)
CADTH COMMON DRUG REVIEW Clinical Review Report (Sample) GENERIC DRUG NAME (BRAND NAME) (Manufacturer) Indication: Text Disclaimer: The information in this document is intended to help Canadian health
More informationBALCHEM CORPORATION. Q Investor Relations Presentation
BALCHEM CORPORATION Q4 2017 Investor Relations Presentation Balchem Corporation Balchem develops, manufactures, and markets specialty ingredients that improve and enhance the health and well being of life
More informationGlobal Epilepsy Market: Industry Analysis & Outlook
Industry Research by Koncept Analytics Global Epilepsy Market: Industry Analysis & Outlook ----------------------------------------- February 2017 1 Executive Summary Epilepsy is a group of neurological
More informationGlobal Prefilled Syringes Market: Trends, Opportunities and Forecasts ( )
Global Prefilled Syringes Market: Trends, Opportunities and Forecasts (2016-2021) By Material - Glass and Plastic By Filling Capabilities Single Chamber and Dual/Multiple Chamber By Major Applications
More informationSPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS
SPHERIX Investor Relations Phone: (301) 897-2564 Email: info@spherix.com SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS BETHESDA, MD, May 21, 2010 - Spherix Incorporated (NASDAQ CM: SPEX), an innovator
More informationObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update
ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update - All Three Development Compounds Progressing with Key Clinical Milestones Over the Next 12 Months - Geneva, Switzerland
More informationThis is a licensed product of Ken Research and should not be copied
1 TABLE OF CONTENTS 1. The US Diabetes Care Devices Market Introduction 1.1. What is Diabetes and it s Types? 2. The US Diabetes Care Devices Market Size, 2007-2013 3. The US Diabetes Care Devices Market
More informationThromboGenics Business Update H1 2018
Press release 6 September 2018 Regulated Information ThromboGenics Business Update H1 2018 Positive Topline Results for Diabetic Eye Disease Portfolio Shareholder approval for company name change to Oxurion
More informationIndustry experience in consortium i.e. from BEE party or non-bee partners
A. ENTREPRENEURSHIP FINANCE Imbewu Entrepreneurship Finance would provides risk capital to new businesses and to early stage businesses owned and managed by black people meeting the following criteria:
More informationAn exciting combination in a high growth, high margin Nutrition category. Name of chairman
An exciting combination in a high growth, high margin Nutrition category 2 Vevey, December 14, 2006 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationFirst Quarter Results to March 31, Shire plc April 25, 2008
First Quarter Results to March 31, 2008 Shire plc April 25, 2008 THE SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 Statements included herein that are not historical
More informationMDxHealth. Excellent Buy Opportunity. Research Note.
Research Note MDxHealth Excellent Buy Opportunity Chief Research Analyst Marcel Wijma MSc +1 (917) 460 6185 (US) +31 (6) 8489 2954 (NL) m.wijma@leeuwenhoeck.com http://www.leeuwenhoeck.com Date: 29 February
More informationEnel Américas 1Q 2018 results
Enel Américas 1Q 2018 results 1Q 2018 results Highlights of the period EBITDA of 820 musd, an increase of 26% vs 1Q 2017 Generation EBITDA increased by 17% due to better prices in Argentina and consolidation
More informationSpiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria
Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria FINANCIAL TIMES INVESTING IN BULGARIA CONFERENCE Investment Opportunities in Bulgaria The Case of Solvay Sodi Spiros Nomikos CEO of Solvay Sodi
More information1Q 2015 Results A Positive Start to 2015
1Q 2015 Results Main Events Operating Results Order Backlog Financial Performance Update on Disposal 1Q 2015 Results A Positive Start to 2015 Rome - May 14, 2015 1Q 2015 Main Backlog Events 1Q 2015 Results
More informationAsia-Pacific Bariatric Surgery Devices Market Outlook to 2020
Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List
More informationDISCLOSEABLE AND CONNECTED TRANSACTION AND PROPOSED APPOINTMENT OF CHIEF EXECUTIVE OFFICER
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness
More informationChina Human Vaccine Industry Report, Jun. 2016
China Human Vaccine Industry Report, 2016-2020 Jun. 2016 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationVolitionRx Announces First Quarter 2016 Financial Results and Business Update
May 13, 2016 VolitionRx Announces First Quarter 2016 Financial Results and Business Update NAMUR, Belgium, May 13, 2016 /PRNewswire/ -- VolitionRx Limited (NYSE MKT: VNRX), a life sciences company focused
More informationForward-Looking Statements
Investor Presentation May 2012 Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended.
More informationUCB, with a strong year 2017, is reinforcing a solid foundation for investing in future growth
Brussels (Belgium), February 018 7:00 (CET) regulated information UCB Full Year Report 017: UCB, with a strong year 017, is reinforcing a solid foundation for investing in future growth Positive growth
More informationConsolidated: Financial Summary
FY2010 First Quarter Financial Results SUZUKI MOTOR CORPORATION 3 August 2010 Consolidated: Financial Summary Page2 FY2010 1Q FY2009 1Q (2010/4-6) (2009/4-6) Change Net sales 656.3 577.1 +79.2 +13.7% Operating
More informationEssential Oil & Aromatherapy Market Research Report- Forecast to 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/3319 Essential Oil & Aromatherapy Market Research Report- Forecast to 2023 Report / Search Code: MRFR/F-B & N/2386-HCRR
More informationStraumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America
Media release Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America Group net revenue rises 2% (l.c.) as double-digit increases across America offset
More informationSwedencare. Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind Swedencare Summary An Animal Health care company with global presence in a fast growing market Sales in 50 countries, both with fully owned
More informationPhotoCure ASA. Presentation. Results 1 Quarter 2004
PhotoCure ASA Presentation Results 1 Quarter 2004 7 th of May 2004 Progress towards sustained profitability Continued product roll out Metvix European sales continue to grow Final US approval for Actinic
More information